
Karina Ninni
Articles
-
Dec 6, 2024 |
medicalxpress.com | Karina Ninni
Pancreatic cancer has recently been included in the list of diseases about which Brazil's National Cancer Institute (INCA) periodically publishes statistics. Although it is not the most frequent type of cancer, its high lethality makes it one of the leading causes of death from cancer in Brazil, partly owing to late diagnosis. "It's striking how little data on the disease is available in Brazil and indeed in Latin America as a whole.
-
May 16, 2024 |
flipboard.com | Karina Ninni
-
May 5, 2024 |
newsbreak.com | Karina Ninni
Welcome to NewsBreak, an open platform where diverse perspectives converge. Most of our content comes from established publications and journalists, as well as from our extensive network of tens of thousands of creators who contribute to our platform. We empower individuals to share insightful viewpoints through short posts and comments.
-
May 5, 2024 |
scitechdaily.com | Karina Ninni
Scientists Sequence Arabica Genome, Opening Doors to Climate-Resilient Coffee By Karina Ninni, São Paulo Research Foundation (FAPESP) May 5, 2024Scientists have recently sequenced the genome of Coffea arabica, revealing genetic insights that could lead to disease-resistant and climate-adapted coffee varieties. This breakthrough enables both guided crossbreeding and targeted genetic modifications, enhancing our understanding of the coffee’s disease resistance and aroma characteristics.
-
Apr 23, 2024 |
terra.com.br | Karina Ninni
Ocaféé uma das commodities mais negociadas no mundo e a espécie Coffea arabica é a mais consumida entre as cerca de 130 existentes. Ela é o resultado da fusão de duas outras espécies: Coffea canephora (conhecido no Brasil como café conilon ou robusta) e Coffea eugenioides. Nos últimos dez anos, quase todas as grandes commodities do mundo tiveram um genoma de referência sequenciado, mas o café só recentemente passou a integrar essa lista.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →